Overview
My research has focused on mitochondrial functions in cancer metabolism and understand the role of mitochondrial dynamics in cellular function and human diseases including cancers. Additionally, I also continuously dissect cancer metabolism and identifying potential metabolic vulnerabilities of cancer initiation, progression and metastasis using several in vitro, ex vivo and in vivo genetical approaches such as CRISPR/Cas9 knockout, mouse/ human organoid cultures and genetically engineered mouse models, thereby characterizing molecular mechanisms regulated by metabolic pathways and developing potential metabolic interventions for targeting cancers.
Current Appointments & Affiliations
Assistant Professor of Pathology
·
2023 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2024 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Mitochondrial Dynamics in Cancer Progression and Therapy Resistance: Emerging Roles in Metabolic Reprogramming, Biomarker Discovery, and Precision Medicine.
Journal Article Cells · June 2, 2026 Mitochondria play essential roles in cellular metabolism and signaling, regulating biosynthetic pathways, calcium homeostasis, redox balance, and cell fate beyond ATP production. Their continual remodeling through fusion, fission, and mitophagy maintains m ... Full text Link to item CiteGlucose metabolism and its direct action in cancer and immune regulation: opportunities and challenges for metabolic targeting.
Journal Article J Biomed Sci · July 29, 2025 Glucose metabolism is a pivotal hub for cellular energy production and the generation of building blocks that support cell growth, survival, and differentiation. Cancer cells undergo metabolic reprogramming to sustain rapid proliferation, survive in harsh ... Full text Open Access Link to item CiteCD36-mediated endocytosis of proteolysis-targeting chimeras.
Journal Article Cell · June 12, 2025 Passive diffusion does not explain why many drugs are too large and/or too polar for rule-breaking membrane penetration, such as proteolysis-targeting chimeras (PROTACs, generally of a molecular weight > 800 Da). Here, using biotinylated chemical-probe-bas ... Full text Link to item CiteRecent Grants
Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancer
ResearchAssistant Research Professor · Awarded by National Cancer Institute · 2023 - 2028Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance
ResearchCollaborator · Awarded by National Cancer Institute · 2023 - 2027View All Grants
Education
National Cheng Kung University (Taiwan) ·
2014
Ph.D.